Tests AI-guided heart ultrasound in people with heart failure or valve disease
Compares AI-guided and standard heart ultrasound to guide care in adults with heart disease.
Plain-language title generated from the registry record
Registry title: Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment
Key facts
- Where
- Alice Springs, AustraliaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults over 45 in rural and remote Australia who have trouble with exercise or heart risk factors, to test AI-guided heart ultrasound.
- Age
- Over 45 years
- Sex
- All sexes can join.
- Disease stage
- People without known heart failure or valve heart disease. They need exercise intolerance or heart and blood vessel risk factors.
Main reasons for not taking part
- Known heart failure or valve heart disease
- Situations where heart protection is already indicated, for example known coronary artery disease
- Other conditions with life expectancy under 2 years
- Cannot give written informed consent
Read by machine on 12 November 2026.
Where in Australia
- Alice Springs HospitalAlice Springs, AustraliaContact: Angus Baumann, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Baker Heart and Diabetes Institute
- Trial code
- NCT05558605
- Record updated
- 30 September 2026
- Original description
Heart Failure and valvular heart disease are disproportionate problems in rural and remote Australia (RRA). Echocardiography is the best imaging investigation, and essential for management, but access to this essential test shows huge geographic variations, primarily because of dependence on expert acquisition. This trial seeks to demonstrate the effectiveness of artificial intelligence-based echocardiography for triage and management of patients with known or suspected heart disease in RRA.Read full original descriptionShow less
Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment
Heart Failure and valvular heart disease are disproportionate problems in rural and remote Australia (RRA). Echocardiography is the best imaging investigation, and essential for management, but access to this essential test shows huge geographic variations, primarily because of dependence on expert acquisition. This trial seeks to demonstrate the effectiveness of artificial intelligence-based echocardiography for triage and management of patients with known or suspected heart disease in RRA.
Inclusion: Age >45 years; eligible for Medicare; exercise intolerance or cardiovascular (CV) risk factors.
Exclusion: comorbid conditions with life expectancy <2 years; Known HF or HVD; situations where cardio-protection is already indicated (eg. known CAD); inability to provide written informed consent.